Initial data from the Phase 1 dose escalation trial in 18 patients with advanced solid tumors shows AMV564 administered subcutaneously was well tolerated, with no dose-limiting toxicities AMV564...

Amphivena Therapeutics, a clinical-stage immuno-oncology company focused on developing immunotherapeutics that restore anti-cancer immunity to the patient, today announced that Curtis Ruegg,...

Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, today announced that two presentations were accepted at the 2020 American Society of Clinical...

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, will present results from a study today that characterize KRAS mutations in...

Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today presented data from the first clinical studies...

COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce its involvement and participation in two industry leading...

Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of...

Jennifer Hamann, chief financial officer of Union Pacific Corporation (NYSE: UNP), will address the following investor conferences in June: UBS Global Industrials and Transportation Virtual Conference

Salesforce (NYSE: CRM), the global leader in CRM, today announced that Salesforce executives will participate in the following investor events: Monday, June 1, 2020: Adam Blitzer, EVP & GM,...

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases,...